Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition.
about
Caspase-9: structure, mechanisms and clinical applicationLongitudinal tracking of subpopulation dynamics and molecular changes during LNCaP cell castration and identification of inhibitors that could target the PSA-/lo castration-resistant cells.Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancerBcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.The chemomodulatory effects of glufosfamide on docetaxel cytotoxicity in prostate cancer cells.Brachyury as a potential modulator of androgen receptor activity and a key player in therapy resistance in prostate cancer.Marine compound rhizochalinin shows high in vitro and in vivo efficacy in castration resistant prostate cancer.Suppression of miR-4735-3p in androgen receptor-expressing prostate cancer cells increases cell death during chemotherapy.The Emerging Role of Extracellular Vesicle-Mediated Drug Resistance in Cancers: Implications in Advanced Prostate CancerDocetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells.The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer.Marine alkaloid Monanchocidin a overcomes drug resistance by induction of autophagy and lysosomal membrane permeabilization.Targeting MRP4 expression by anti-androgen treatment reverses MRP4-mediated docetaxel resistance in castration-resistant prostate cancerBH3 Mimetics for the Treatment of Prostate Cancer.Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell propertiesExperimental study of doxorubicin interventional chemotherapy in the treatment of rabbit VX2 renal transplantation carcinoma.Synergistic cytotoxicity of a prostate cancer-specific immunotoxin in combination with the BH3 mimetic ABT-737.Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation.Pathways and mechanisms of venetoclax resistance.Fibronectin protects lung cancer cells against docetaxel-induced apoptosis by promoting Src and caspase-8 phosphorylation.Synthesis and anticancer activity of the derivatives of marine compound rhizochalin in castration resistant prostate cancer.The presence and clinical implication of intraductal carcinoma of prostate in metastatic castration resistant prostate cancer.Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin.The Orexin-A-Regulated Akt/mTOR Pathway Promotes Cell Proliferation Through Inhibiting Apoptosis in Pancreatic Cancer Cells
P2860
Q33618946-60EBF754-13BD-4352-AF9C-3ED574AE0B1FQ35922320-B6C35F1D-874A-4FB7-BC9D-6A1561ED6729Q36546746-393BAC21-AEC5-4625-BD09-ECDB9C283D96Q36561621-FFB5A065-EE39-4BD8-8049-9B571CCCD8A8Q37065525-205F189C-60D4-44BD-ABA3-6022D13593CEQ37301697-7544E625-D5E0-4D6A-ABE9-F51E56F46699Q37688428-95D17949-8F3A-4480-9116-217827056EE2Q38598782-0F25855B-BBAC-431A-8D54-3D4688E7342AQ38639852-D7F11E8A-AB6A-4A7E-A678-F57A0DC37CA2Q38777929-198216C4-9F78-417C-A51D-F1F4593B68E2Q38809660-D0E62890-89B6-41EF-9959-C02569E8442CQ38861914-CCC7B4EA-79D5-43D3-BC9D-6D81D40EB865Q41143231-76A9D1D0-942C-4656-B15C-EB357104CC42Q41463153-F46EE051-E7AF-4BEF-8039-105D2F0427E9Q42078200-D0B495F2-413E-4F29-8264-F9C69A985670Q43181443-5089726A-E7C8-48AD-8ADD-8231236F9515Q47349096-B18D991A-01C1-4597-84C5-100CD3DBAA58Q50879597-7D7332F8-8DEC-456E-BCD5-06B5FB10FE1DQ51160342-544F4871-B489-4B70-BA1B-ABD7E3FFB5E8Q51611913-463A8128-E8FF-4ACB-A5C3-4FBC218BE5CAQ52571246-4D5D9CFC-366D-4A37-B84F-2929F2317E8FQ53527594-8CCB8EC2-77A0-4106-8863-CFA751968AA2Q55073638-0109CA2F-5A1D-40E7-A8B9-DF2C11BABFD9Q59133590-61C78857-CE12-4FA4-9B15-D3FA7F0A5580
P2860
Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Bcl-2 family inhibition sensit ...... is under caspase-9 inhibition.
@en
type
label
Bcl-2 family inhibition sensit ...... is under caspase-9 inhibition.
@en
prefLabel
Bcl-2 family inhibition sensit ...... is under caspase-9 inhibition.
@en
P2093
P2860
P356
P1433
P1476
Bcl-2 family inhibition sensit ...... is under caspase-9 inhibition.
@en
P2093
Hiroaki Shiina
Hiroki Tamaki
Kohji Naora
Mamoru Harada
Miho Hiraki
Nanae Harashima
Naoko Arichi
Nobuhiro Nishimura
P2860
P304
11399-11412
P356
10.18632/ONCOTARGET.2550
P407
P577
2014-11-01T00:00:00Z